India · Delayed Price · Currency is INR Verve Therapeutics Statistics
Total Valuation
NSE:COLPAL has a market cap or net worth of INR 613.68 billion. The enterprise value is 607.61 billion.
| Market Cap | 613.68B |
| Enterprise Value | 607.61B |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | May 28, 2025 |
Share Statistics
| Current Share Class | 271.99M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 132.12M |
Valuation Ratios
The trailing PE ratio is 44.04 and the forward PE ratio is 41.75.
| PE Ratio | 44.04 |
| Forward PE | 41.75 |
| PS Ratio | 10.27 |
| PB Ratio | 36.87 |
| P/TBV Ratio | 36.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 43.60 |
| EV / Sales | 10.16 |
| EV / EBITDA | 31.82 |
| EV / EBIT | 34.75 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | n/a |
| Interest Coverage | 401.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 59.53% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 27.20M |
| Profits Per Employee | 6.34M |
| Employee Count | 2,198 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:COLPAL has paid 4.79 billion in taxes.
| Income Tax | 4.79B |
| Effective Tax Rate | 25.59% |
Stock Price Statistics
The stock price has decreased by -33.82% in the last 52 weeks. The beta is 0.31, so NSE:COLPAL's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -33.82% |
| 50-Day Moving Average | 2,396.22 |
| 200-Day Moving Average | 2,630.13 |
| Relative Strength Index (RSI) | 34.77 |
| Average Volume (20 Days) | 750,983 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:COLPAL had revenue of INR 59.78 billion and earned 13.93 billion in profits. Earnings per share was 51.24.
| Revenue | 59.78B |
| Gross Profit | 40.97B |
| Operating Income | 17.48B |
| Pretax Income | 18.73B |
| Net Income | 13.93B |
| EBITDA | 18.92B |
| EBIT | 17.48B |
| Earnings Per Share (EPS) | 51.24 |
Balance Sheet
The company has 6.68 billion in cash and 608.40 million in debt, giving a net cash position of 6.07 billion.
| Cash & Cash Equivalents | 6.68B |
| Total Debt | 608.40M |
| Net Cash | 6.07B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 16.64B |
| Book Value Per Share | 61.20 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 68.54%, with operating and profit margins of 29.25% and 23.31%.
| Gross Margin | 68.54% |
| Operating Margin | 29.25% |
| Pretax Margin | 31.33% |
| Profit Margin | 23.31% |
| EBITDA Margin | 31.65% |
| EBIT Margin | 29.25% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 51.00, which amounts to a dividend yield of 2.26%.
| Dividend Per Share | 51.00 |
| Dividend Yield | 2.26% |
| Dividend Growth (YoY) | -12.07% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 2.27% |
| Earnings Yield | 2.27% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 23, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Sep 23, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |